Literature DB >> 31423671

Role of the non-hypervariable FR3 D-E loop in single-domain antibody recognition of haptens and carbohydrates.

Kevin A Henry1,2, Greg Hussack1, Jyothi Kumaran1, Michel Gilbert1, C Roger MacKenzie1, Traian Sulea3, Mehdi Arbabi-Ghahroudi1,4.   

Abstract

Single-domain antibodies (sdAbs), the variable domains of camelid heavy chain-only antibodies, are generally thought to poorly recognize nonproteinaceous small molecules and carbohydrates in comparison with conventional antibodies. However, the structures of anti-methotrexate, anti-triclocarban and anti-cortisol sdAbs revealed unexpected contributions of the non-hypervariable "CDR4" loop, formed between β-strands D and E of framework region 3, in binding. Here, we investigated the potential role of CDR4 in sdAb binding to a hapten, 15-acetyl-deoxynivalenol (15-AcDON), and to carbohydrates. We constructed and panned a phage-displayed library in which CDR4 of the 15-AcDON-specific sdAb, NAT-267, was extended and randomized. From this library, we identified one sdAb, MA-232, bearing a 14-residue insertion in CDR4 and showing improved binding to 15-AcDON by ELISA and surface plasmon resonance. On the basis of these results, we constructed a second set of phage-displayed libraries in which the CDR4 and other regions of three hapten- or carbohydrate-binding sdAbs were diversified. With the goal of identifying sdAbs with novel glycan-binding specificities, we panned the library against four tumor-associated carbohydrate antigens but were unable to enrich binding phages. Thus, we conclude that while CDR4 may play a role in binding of some rare hapten-specific sdAbs, diversifying this region through molecular engineering is probably not a general solution to sdAb carbohydrate recognition in the absence of a paired VL domain.
© 2019 National Research Council Canada. Journal of Molecular Recognition © 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  15-acetyl-deoxynivalenol; CDR4; VHH; carbohydrate; hapten; heavy chain-only antibody; phage display; single-domain antibody

Mesh:

Substances:

Year:  2019        PMID: 31423671     DOI: 10.1002/jmr.2805

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  1 in total

1.  Chemiluminescent Enzyme Immunoassay and Bioluminescent Enzyme Immunoassay for Tenuazonic Acid Mycotoxin by Exploitation of Nanobody and Nanobody-Nanoluciferase Fusion.

Authors:  Feng Wang; Zhen-Feng Li; Yuan-Yuan Yang; De-Bin Wan; Natalia Vasylieva; Yu-Qi Zhang; Jun Cai; Hong Wang; Yu-Dong Shen; Zhen-Lin Xu; Bruce D Hammock
Journal:  Anal Chem       Date:  2020-08-11       Impact factor: 6.986

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.